Skip to content
★ Sign in to follow
JA

Jules A. Musing

Board Director
Director
TherapeuticsMD, Inc.
Total declarations
6
Company
1
▲ Purchases (3 ops.)
€19k
▼ Sales (1 ops.)
€89k

Latest filing published 22 Aug 2022 for TherapeuticsMD, Inc..

Filing timeline

BuySale
Jules A. Musing

Insider track record

Disclosed buys
3
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+121.2%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 Aug 2013 · 4821 days ago · €10k
    +123.1%
    Entry US$104.00 · Close at T+365 US$232.00
  • Filed 27 Aug 2013 · 4822 days ago · €6,971
    +155.8%
    Entry US$108.50 · Close at T+365 US$277.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jules A. Musing: trading record in brief

Jules A. Musing, listed as board member, appears in our data through filings on TherapeuticsMD, Inc. shares, published by SEC (Form 4). Between 23 August 2013 and 18 August 2022, the trades on record add up to 6 filings.

On the open market, the record shows 3 purchases worth €19k and 1 sale worth €89k. Netting one side against the other leaves €70k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 option exercises.

Half of the purchases are above €6,971 and half below. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +121.2%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 22 August 2022, the filings show an option exercise in TherapeuticsMD, Inc. The last insider purchase was made public on 28 August 2013, 4,821 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jules A. Musing

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations